25 February 2015

Phorm Corporation Limited

("Phorm" or the "Company")

Board Changes

Phorm (AIM: PHRM), a leading internet personalisation technology company, announces that Mr Lex Fenwick is being appointed as a Non-Executive Director of the Company and that Lord Lamont has resigned.

Board Changes

Phorm is pleased to announce that Mr Lex Fenwick will be appointed as a Non-Executive Director of the Company on 1 March 2015. Mr Fenwick is former CEO of Dow Jones & Co. and former CEO of Bloomberg L.P. Mr Fenwick brings with him invaluable experience from international finance, data and media businesses. Phorm also announces that Lord Lamont has resigned from the Board with immediate effect.

Kent Ertugrul, Chairman and CEO of Phorm, commented:

"We are delighted to welcome Lex to the Phorm Board. As a world-class CEO his experience will be of huge value as the business moves into the next stage of its development, generating large scale commercial revenue in major markets. We would also like to take this opportunity to thank Lord Lamont for his advice and support over the last 6 years and wish him well for the future."

Lex Fenwick commented:

"I am extremely excited to be joining the board of Phorm at a pivotal stage in its development. I have been watching the business for a considerable period of time and I look forward to helping them scale and reach their commercial potential."

Additional information on Mr Lex Fenwick

The following additional information is provided in accordance with paragraph (g) of Schedule Two to the AIM  Rules for Companies:

Alexius ("Lex") John Benedict Fenwick (aged 55)

There is no other information that is required to be disclosed pursuant to paragraph (g) of Schedule Two to the 
AIM Rules for Companies.

-Ends-

For further information please contact: Phorm Corporation Limited

Andy Croxson (analysts and investors)                                      +44 (0) 203 397 6001

UK Investors

Mirabaud Securities LLP (Broker)                                         +44 (0) 207 321 2508

Jason Woollard 
Peter Krens

Strand Hanson Limited (Nominated Adviser)                        +44 (0) 207 409 3494

James Harris 
Matthew Chandler
James Dance

US Investors

Lippert/Heilshorn and Associates (Investor Relations)           +1 212 838 3777

John Heilshorn

About Phorm

Phorm  is  a  global  personalisation  technology  company  that  makes  content  and  advertising  more  relevant   to
the  consumer.   Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's  industry  leading  technology  enables  its Internet  Service  Provider ("ISP") partners  to  offer  a new type of online
advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.

Phorm's   advertising  platform  revolutionises  current  standards of online privacy, fully protecting the identity of consumers.
Phorm's  solution   is  completely   opt-in.   Only  those  users  consenting  to  the  service  are  profiled  and  only  ever on an anonymous basis.

Phorm's partners include leading ISPs, Publishers, Advertising Networks and Advertisers.

Phorm, under a  predecessor holding  company, was  admitted  to  the  AIM market of  the  London
Stock Exchange in 2004.

For more information, please visit: www.phorm.com